To include your compound in the COVID-19 Resource Center, submit it here.

LAX-101: SPA received

Amarin received an SPA from FDA for the international REDUCE-IT cardiovascular outcomes trial to evaluate AMR101

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE